Divis Laboratories has reported results for third quarter ended December 31, 2016.
The company has reported 8.74% rise in its net profit at Rs 268.32 crore for the quarter under review as compared to Rs 246.76 crore for the same quarter in the previous year. Total income of the company increased by 13.84% at Rs 994.95 crore for the quarter under review as compared to Rs 873.98 crore for the corresponding quarter previous year.
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.